Literature DB >> 28751516

The Use and Utility of Aspiration Thrombectomy in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

D Wei1, J R Mascitelli1, D A Nistal1, C P Kellner1, J T Fifi1,2, J D Mocco1, R A De Leacy3,4.   

Abstract

BACKGROUND: Thrombectomy trials are often specifically interpreted as evidence for the effectiveness of stent retrievers. The effectiveness of other thrombectomy techniques such as aspiration thrombectomy should be validated through further investigation and review.
PURPOSE: To evaluate published treatment times and clinical outcomes in patients treated with aspiration thrombectomy or ADAPT (A Direct Aspiration, First Pass Technique) for acute ischemic stroke. DATA SOURCES: A systematic literature review was performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. MEDLINE, Scopus, and the Cochrane trial register were searched on November 8, 2016. STUDY SELECTION: Twenty studies (n = 1523 patients) were included in this review and meta-analysis. One of these studies was prospective, and the rest were retrospective. DATA ANALYSIS: Meta-analysis was performed by using a random effects model. Data and publication bias were visualized with forest plots and funnel plots. DATA SYNTHESIS: Five studies investigated aspiration thrombectomy only, and 16 studies investigated ADAPT. Of the 16 studies on ADAPT, the rate of successful recanalization (TICI 2b/3) was 89.3% (95% CI, 85.4%-92.3%). The proportion of patients with good clinical outcome (90-day mRS ≤2) was 52.7% (95% CI, 48.0%-57.4%). LIMITATIONS: Studies on ADAPT were retrospective, and there was heterogeneity between studies for successful recanalization (P < .001) and good clinical outcome (P < .001). There was evidence of publication bias for recanalization rates (P = .01), but not for clinical outcomes (P = .42).
CONCLUSIONS: ADAPT and aspiration thrombectomy are effective approaches to thrombectomy, with high recanalization rates and excellent clinical outcomes reported in the literature. Aspiration thrombectomy is a promising neurointervention, but large prospective randomized studies are needed to validate its utility.
© 2017 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2017        PMID: 28751516     DOI: 10.3174/ajnr.A5309

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  5 in total

Review 1.  Novel approaches for the delivery of therapeutics in ischemic stroke.

Authors:  Saeideh Nozohouri; Ali Ehsan Sifat; Bhuvaneshwar Vaidya; Thomas J Abbruscato
Journal:  Drug Discov Today       Date:  2020-01-21       Impact factor: 7.851

2.  A direct aspiration first pass technique with the new ARC catheter for thrombectomy of large vessel occlusion strokes: A multicenter study.

Authors:  Pierre De Marini; Sanjeev Nayak; François Zhu; Serge Bracard; René Anxionnat; Romain Tonnelet; Liang Liao; Sébastien Richard; Lisa Humbertjean; Gioia Mione; Jean-Christophe Lacour; Anne-Laure Derelle; Benjamin Gory
Journal:  Interv Neuroradiol       Date:  2018-10-05       Impact factor: 1.610

3.  Standard Diffusion-Weighted Imaging in the Brain Can Detect Cervical Internal Carotid Artery Dissections.

Authors:  G Adam; J Darcourt; M Roques; M Ferrier; R Gramada; Z Meluchova; S Patsoura; A Viguier; C Cognard; V Larrue; F Bonneville
Journal:  AJNR Am J Neuroradiol       Date:  2020-01-16       Impact factor: 3.825

Review 4.  The progress of research on histone methylation in ischemic stroke pathogenesis.

Authors:  Yaxin Su; Lei Zhang; Yao Zhou; Lei Ding; Li Li; Zhongcheng Wang
Journal:  J Physiol Biochem       Date:  2021-09-02       Impact factor: 4.158

5.  A Technical Report on the Performance of a New Large Bore Cerebral Aspiration Catheter, the First Results.

Authors:  Faysal Benali; Robert-Jan B Goldhoorn; Bart A J M Wagemans; Christiaan van der Leij; Rutger J B Brans; Sanne W de Boer; Michiel W de Haan; Wim H van Zwam
Journal:  Cardiovasc Intervent Radiol       Date:  2019-07-02       Impact factor: 2.740

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.